Home Gilead says hepatitis C treatment's approval is on track
 

Keywords :   


Gilead says hepatitis C treatment's approval is on track

2013-01-07 19:30:14| Biotech - Topix.net

Gilead Sciences is on track to file for regulatory approval of sofosbuvir, its treatment for chronic hepatitis C virus infection, starting in mid-2013, the Foster City biotech company said on Monday.

Tags: on track approval treatments

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
15.11Nintendo 3DSLL.DS lite.DS
15.11
15.11×142cm 3
15.11 selection5 5 3BOX
15.11 40T
15.11Knights
15.11 BIG
15.11 RE-TAKE 3
More »